MARKET

SCLXW

SCLXW

Scilex Holding Company
NASDAQ
0.1937
-0.0139
-6.70%
Closed 14:29 07/24 EDT
OPEN
0.1800
PREV CLOSE
0.2076
HIGH
0.2075
LOW
0.1800
VOLUME
5.67K
TURNOVER
--
52 WEEK HIGH
0.6500
52 WEEK LOW
0.0501
MARKET CAP
--
P/E (TTM)
-0.0049
1D
5D
1M
3M
1Y
5Y
1D
Scilex Announces Strategic Sale of Vivasor Preferred Shares
TipRanks · 2d ago
Weekly Report: what happened at SCLX last week (0713-0717)?
Weekly Report · 5d ago
Weekly Report: what happened at SCLX last week (0706-0710)?
Weekly Report · 07/13 09:44
Scilex Portfolio Company Semnur Pharmaceuticals Receives $100M Investment From iHolding In 10M Newly Issued Shares At $10 Per Share
Benzinga · 07/07 10:05
Semnur signs term sheet for $100 million unregistered share sale to iHolding Group at $10 per share
PUBT · 07/07 10:03
SCILEX HOLDING CO - IHOLDING TO INVEST $100 MLN IN NEWLY ISSUED SEMNUR COMMON STOCK
Reuters · 07/07 10:00
SCILEX HOLDING COMPANY ANNOUNCES DREAM BOWL I MEME COIN TOKENS COMMENCE TRADING ON THE BICONOMY EXCHANGE ON JULY 6, 2026
Reuters · 07/06 15:35
What's Going on With Scilex Holding Stock Monday?
Benzinga · 07/06 13:02
More
About SCLXW
Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system) 1.8%, is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It also focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. Its second commercial product ELYXYB, is a potential first-line treatment, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults. Its product candidates include SP-102 (SEMDEXA), SP-103 and SP-104. SP-102 is a viscous gel formulation of a used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica. Its SP-103 is a triple-strength formulation of ZTlido, for the treatment of chronic neck pain.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLXW stock methods without spending real money on the virtual paper trading platform.